Virtu Financial LLC Vbi Vaccines Inc Transaction History

Virtu Financial LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.66 - $1.81 $53,888 - $147,784	81,649 New	81,649 $66,000
Q1 2022 May 17, 2022	SELL	$1.27 - $2.47 $68,460 - $133,147	-53,906 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$2.21 - $3.22 $119,132 - $173,577	53,906 New	53,906 $126,000
Q3 2021 Nov 12, 2021	SELL	$2.8 - $3.72 $80,203 - $106,555	-28,644 Closed	0 $0
Q2 2021 Sep 17, 2021	SELL	$2.61 - $4.17 $146,640 - $234,287	-56,184 Reduced 66.23%	28,644 $96,000
Q1 2021 May 19, 2021	BUY	$2.91 - $4.32 $179,797 - $266,915	61,786 Added 268.15%	84,828 $264,000
Q4 2020 Feb 24, 2021	BUY	$2.15 - $3.5 $49,540 - $80,647	23,042 New	23,042 $63,000
Q2 2020 Aug 07, 2020	SELL	$0.87 - $3.13 $24,807 - $89,248	-28,514 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$0.48 - $1.38 $111,033 - $319,221	-231,320 Reduced 89.03%	28,514 $39,000
Q3 2019 Nov 20, 2019	BUY	$0.47 - $1.05 $122,121 - $272,825	259,834 New	259,834 $122,000
Q1 2019 Apr 12, 2019	SELL	$1.54 - $2.01 $17,896 - $23,358	-11,621 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$1.22 - $2.41 $14,177 - $28,006	11,621 New	11,621 $19,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.